Lactobacillus gasseri in the Upper Small Intestine Impacts an ACSL3-Dependent Fatty Acid-Sensing Pathway Regulating Whole-Body Glucose Homeostasis

Cell Metabolism

Volumn 27, Issue 3, 2018, Pages 572-587.e6

  Bauer, Paige V ^a,b   Duca, Frank A ^a   Waise, T M Zaved ^a   Dranse, Helen J ^a   Rasmussen, Brittany A ^a,b   Puri, Akshita ^c   Rasti, Mozhgan ^a   O'Brien, Catherine A ^b,c   Lam, Tony K T ^a,b,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

fatty acid sensing; glucose regulation; microbiota; upper small intestine

Indexed keywords

GLUCOSE; INTRALIPID; LINOLEIC ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; OLEIC ACID; PROBIOTIC AGENT; FATTY ACID; PHOSPHOLIPID; SOYBEAN OIL; SOYBEAN OIL, PHOSPHOLIPID EMULSION;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDING; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; INTESTINE FLORA; LACTOBACILLUS GASSERI; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMALL INTESTINE; ANIMAL; C57BL MOUSE; EMULSION; FECAL MICROBIOTA TRANSPLANTATION; HOMEOSTASIS; METABOLISM; MICROBIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; DIET, HIGH-FAT; EMULSIONS; FATTY ACIDS; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; GLUCOSE; HOMEOSTASIS; INTESTINE, SMALL; LACTOBACILLUS GASSERI; LINOLEIC ACID; MICE, INBRED C57BL; OLEIC ACID; PHOSPHOLIPIDS; RATS, SPRAGUE-DAWLEY; SOYBEAN OIL;

EID: 85042679593     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2018.01.013     Document Type: Article

References (108)

1. Almiron, M., Traglia, G., Rubio, A., Sanjuan, N., Colonization of the mouse upper gastrointestinal tract by Lactobacillus murinus: a histological, immunocytochemical, and ultrastructural study. Curr. Microbiol. 67 (2013), 395–398.
2. Asemi, Z., Zare, Z., Shakeri, H., Sabihi, S.S., Esmaillzadeh, A., Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann. Nutr. Metab. 63 (2013), 1–9.
3. Backhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., Semenkovich, C.F., Gordon, J.I., The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 101 (2004), 15718–15723.
4. Balakumar, M., Prabhu, D., Sathishkumar, C., Prabu, P., Rokana, N., Kumar, R., Raghavan, S., Soundarajan, A., Grover, S., Batish, V.K., et al. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. Eur. J. Nutr., 2016, 10.1007/s00394-016-1317-7.
5. Bartram, A.K., Lynch, M.D., Stearns, J.C., Moreno-Hagelsieb, G., Neufeld, J.D., Generation of multimillion-sequence 16S rRNA gene libraries from complex microbial communities by assembling paired-end illumina reads. Appl. Environ. Microbiol. 77 (2011), 3846–3852.
6. Batterham, R.L., Cummings, D.E., Mechanisms of diabetes improvement following bariatric/metabolic surgery. Diabetes Care 39 (2016), 893–901.
7. Bauer, P.V., Duca, F.A., Waise, T.M.Z., Rasmussen, B.A., Abraham, M.A., Dranse, H.J., Puri, A., O'Brien, C.A., Lam, T.K.T., Metformin alters upper small intestinal microbiota that impact a glucose-SGLT1-sensing glucoregulatory pathway. Cell Metab. 27 (2018), 101–117.e5 Published online October 19, 2017.
8. Beysen, C., Murphy, E.J., Deines, K., Chan, M., Tsang, E., Glass, A., Turner, S.M., Protasio, J., Riiff, T., Hellerstein, M.K., Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study. Diabetologia 55 (2012), 432–442.
9. Bowman, T.A., O'Keeffe, K.R., D'Aquila, T., Yan, Q.W., Griffin, J.D., Killion, E.A., Salter, D.M., Mashek, D.G., Buhman, K.K., Greenberg, A.S., Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption. Mol. Metab. 5 (2016), 210–220.
10. Breen, D.M., Rasmussen, B.A., Kokorovic, A., Wang, R., Cheung, G.W., Lam, T.K., Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat. Med. 18 (2012), 950–955.
11. Breen, D.M., Yue, J.T., Rasmussen, B.A., Kokorovic, A., Cheung, G.W., Lam, T.K., Duodenal PKC-delta and cholecystokinin signaling axis regulates glucose production. Diabetes 60 (2011), 3148–3153.
12. Brubaker, P.L., Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. Endocrinology 128 (1991), 3175–3182.
13. Cani, P.D., Joly, E., Horsmans, Y., Delzenne, N.M., Oligofructose promotes satiety in healthy human: a pilot study. Eur. J. Clin. Nutr. 60 (2006), 567–572.
14. Cani, P.D., Knauf, C., Iglesias, M.A., Drucker, D.J., Delzenne, N.M., Burcelin, R., Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55 (2006), 1484–1490.
15. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Pena, A.G., Goodrich, J.K., Gordon, J.I., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7 (2010), 335–336.
16. Chang, C.H., Chey, W.Y., Chang, T.M., Cellular mechanism of sodium oleate-stimulated secretion of cholecystokinin and secretin. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000), G295–G303.
17. Cheung, G.W., Kokorovic, A., Lam, C.K., Chari, M., Lam, T.K., Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab. 10 (2009), 99–109.
18. Chisholm, C., Greenberg, G.R., Somatostatin-28 regulates GLP-1 secretion via somatostatin receptor subtype 5 in rat intestinal cultures. Am. J. Physiol. Endocrinol. Metab. 283 (2002), E311–E317.
19. Choi, S.B., Lew, L.C., Yeo, S.K., Nair Parvathy, S., Liong, M.T., Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenario. Crit. Rev. Biotechnol. 35 (2015), 392–401.
20. Clarysse, S., Tack, J., Lammert, F., Duchateau, G., Reppas, C., Augustijns, P., Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states. J. Pharm. Sci. 98 (2009), 1177–1192.
21. Cote, C.D., Rasmussen, B.A., Duca, F.A., Zadeh-Tahmasebi, M., Baur, J.A., Daljeet, M., Breen, D.M., Filippi, B.M., Lam, T.K., Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network. Nat. Med. 21 (2015), 498–505.
22. Dailey, M.J., Moghadam, A.A., Moran, T.H., Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implications for the effectiveness of Roux-en-Y gastric bypass. Am. J. Physiol. Endocrinol. Metab. 301 (2011), E1184–E1190.
23. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
24. de la Cuesta-Zuluaga, J., Mueller, N.T., Corrales-Agudelo, V., Velasquez-Mejia, E.P., Carmona, J.A., Abad, J.M., Escobar, J.S., Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care 40 (2017), 54–62.
25. Defronzo, R.A., Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58 (2009), 773–795.
26. Degirolamo, C., Rainaldi, S., Bovenga, F., Murzilli, S., Moschetta, A., Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep. 7 (2014), 12–18.
27. Derrien, M., Van Baarlen, P., Hooiveld, G., Norin, E., Muller, M., de Vos, W.M., Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front. Microbiol., 2, 2011, 166.
28. DeSantis, T.Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E.L., Keller, K., Huber, T., Dalevi, D., Hu, P., Andersen, G.L., Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72 (2006), 5069–5072.
29. Di Luccia, B., Crescenzo, R., Mazzoli, A., Cigliano, L., Venditti, P., Walser, J.C., Widmer, A., Baccigalupi, L., Ricca, E., Iossa, S., Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity. PLoS One, 10, 2015, e0134893.
30. Diakogiannaki, E., Pais, R., Tolhurst, G., Parker, H.E., Horscroft, J., Rauscher, B., Zietek, T., Daniel, H., Gribble, F.M., Reimann, F., Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor. Diabetologia 56 (2013), 2688–2696.
31. Duca, F.A., Bauer, P.V., Hamr, S.C., Lam, T.K., Glucoregulatory relevance of small intestinal nutrient sensing in physiology, bariatric surgery, and pharmacology. Cell Metab. 22 (2015), 367–380.
32. Duca, F.A., Cote, C.D., Rasmussen, B.A., Zadeh-Tahmasebi, M., Rutter, G.A., Filippi, B.M., Lam, T.K., Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat. Med. 21 (2015), 506–511.
33. Ejtahed, H.S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M., Mofid, V., Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 28 (2012), 539–543.
34. El Aidy, S., Merrifield, C.A., Derrien, M., van Baarlen, P., Hooiveld, G., Levenez, F., Dore, J., Dekker, J., Holmes, E., Claus, S.P., et al. The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation. Gut 62 (2013), 1306–1314.
35. Everard, A., Cani, P.D., Diabetes, obesity and gut microbiota. Best Pract. Res. Clin. Gastroenterol. 27 (2013), 73–83.
36. Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., Krogh Pedersen, H., et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528 (2015), 262–266.
37. Gareau, M.G., Ho, N.K., Brenner, D., Sousa, A.J., Lebourhis, L., Mak, T.W., Girardin, S.E., Philpott, D.J., Sherman, P.M., Enterohaemorrhagic, but not enteropathogenic, Escherichia coli infection of epithelial cells disrupts signalling responses to tumour necrosis factor-alpha. Microbiology 157 (2011), 2963–2973.
38. Giannakis, M., Backhed, H.K., Chen, S.L., Faith, J.J., Wu, M., Guruge, J.L., Engstrand, L., Gordon, J.I., Response of gastric epithelial progenitors to Helicobacter pylori isolates obtained from Swedish patients with chronic atrophic gastritis. J. Biol. Chem. 284 (2009), 30383–30394.
39. Greenberg, D., Kava, R.A., Lewis, D.R., Greenwood, M.R., Smith, G.P., Time course for entry of intestinally infused lipids into blood of rats. Am. J. Physiol. 269 (1995), R432–R436.
40. Gribble, F.M., Williams, L., Simpson, A.K., Reimann, F., A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52 (2003), 1147–1154.
41. Gu, S., Chen, D., Zhang, J.N., Lv, X., Wang, K., Duan, L.P., Nie, Y., Wu, X.L., Bacterial community mapping of the mouse gastrointestinal tract. PLoS One, 8, 2013, e74957.
42. Hansen, L., Hartmann, B., Bisgaard, T., Mineo, H., Jorgensen, P.N., Holst, J.J., Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum. Am. J. Physiol. Endocrinol. Metab. 278 (2000), E1010–E1018.
43. Hundal, R.S., Krssak, M., Dufour, S., Laurent, D., Lebon, V., Chandramouli, V., Inzucchi, S.E., Schumann, W.C., Petersen, K.F., Landau, B.R., et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49 (2000), 2063–2069.
44. Iakoubov, R., Ahmed, A., Lauffer, L.M., Bazinet, R.P., Brubaker, P.L., Essential role for protein kinase Czeta in oleic acid-induced glucagon-like peptide-1 secretion in vivo in the rat. Endocrinology 152 (2011), 1244–1252.
45. Iakoubov, R., Izzo, A., Yeung, A., Whiteside, C.I., Brubaker, P.L., Protein kinase Czeta is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells. Endocrinology 148 (2007), 1089–1098.
46. Jeun, J., Kim, S., Cho, S.Y., Jun, H.J., Park, H.J., Seo, J.G., Chung, M.J., Lee, S.J., Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice. Nutrition 26 (2010), 321–330.
47. Jiang, C., Xie, C., Lv, Y., Li, J., Krausz, K.W., Shi, J., Brocker, C.N., Desai, D., Amin, S.G., Bisson, W.H., et al. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat. Commun., 6, 2015, 10166.
48. Jiao, J., Bae, E.J., Bandyopadhyay, G., Oliver, J., Marathe, C., Chen, M., Hsu, J.Y., Chen, Y., Tian, H., Olefsky, J.M., et al. Restoration of euglycemia after duodenal bypass surgery is reliant on central and peripheral inputs in Zucker fa/fa rats. Diabetes 62 (2013), 1074–1083.
49. Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergstrom, G., Behre, C.J., Fagerberg, B., Nielsen, J., Backhed, F., Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (2013), 99–103.
50. Kokorovic, A., Cheung, G.W., Breen, D.M., Chari, M., Lam, C.K., Lam, T.K., Duodenal mucosal protein kinase C-delta regulates glucose production in rats. Gastroenterology 141 (2011), 1720–1727.
51. Kovatcheva-Datchary, P., Nilsson, A., Akrami, R., Lee, Y.S., De Vadder, F., Arora, T., Hallen, A., Martens, E., Bjorck, I., Backhed, F., Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab. 22 (2015), 971–982.
52. Kuhre, R.E., Frost, C.R., Svendsen, B., Holst, J.J., Molecular mechanisms of glucose-stimulated GLP-1 secretion from perfused rat small intestine. Diabetes 64 (2015), 370–382.
53. Kumar, R., Grover, S., Batish, V.K., Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague-Dawley rats. Br. J. Nutr. 105 (2011), 561–573.
54. Lam, T.K., Neuronal regulation of homeostasis by nutrient sensing. Nat. Med. 16 (2010), 392–395.
55. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.M., Kennedy, S., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546.
56. Li, F., Jiang, C., Krausz, K.W., Li, Y., Albert, I., Hao, H., Fabre, K.M., Mitchell, J.B., Patterson, A.D., Gonzalez, F.J., Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat. Commun., 4, 2013, 2384.
57. Liu, J., Kandasamy, S., Zhang, J., Kirby, C.W., Karakach, T., Hafting, J., Critchley, A.T., Evans, F., Prithiviraj, B., Prebiotic effects of diet supplemented with the cultivated red seaweed Chondrus crispus or with fructo-oligo-saccharide on host immunity, colonic microbiota and gut microbial metabolites. BMC Complement. Altern. Med., 15, 2015, 279.
58. Lye, H.S., Kato, T., Low, W.Y., Taylor, T.D., Prakash, T., Lew, L.C., Ohno, H., Liong, M.T., Lactobacillus fermentum FTDC 8312 combats hypercholesterolemia via alteration of gut microbiota. J. Biotechnol. 262 (2017), 75–83.
59. Mansbach, C.M. 2nd, Cohen, R.S., Leff, P.B., Isolation and properties of the mixed lipid micelles present in intestinal content during fat digestion in man. J. Clin. Invest. 56 (1975), 781–791.
60. Marina, A.L., Utzschneider, K.M., Wright, L.A., Montgomery, B.K., Marcovina, S.M., Kahn, S.E., Colesevelam improves oral but not intravenous glucose tolerance by a mechanism independent of insulin sensitivity and beta-cell function. Diabetes Care 35 (2012), 1119–1125.
61. Masella, A.P., Bartram, A.K., Truszkowski, J.M., Brown, D.G., Neufeld, J.D., PANDAseq: paired-end assembler for illumina sequences. BMC Bioinformatics, 13, 2012, 31.
62. Mashek, D.G., Li, L.O., Coleman, R.A., Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. J. Lipid Res. 47 (2006), 2004–2010.
63. Morgan, K., Obici, S., Rossetti, L., Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J. Biol. Chem. 279 (2004), 31139–31148.
64. Neyrinck, A.M., Van Hee, V.F., Piront, N., De Backer, F., Toussaint, O., Cani, P.D., Delzenne, N.M., Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutr. Diabetes, 2, 2012, e28.
65. Parseus, A., Sommer, N., Sommer, F., Caesar, R., Molinaro, A., Stahlman, M., Greiner, T.U., Perkins, R., Backhed, F., Microbiota-induced obesity requires farnesoid X receptor. Gut 66 (2017), 429–437.
66. Perry, R.J., Peng, L., Barry, N.A., Cline, G.W., Zhang, D., Cardone, R.L., Petersen, K.F., Kibbey, R.G., Goodman, A.L., Shulman, G.I., Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome. Nature 534 (2016), 213–217.
67. Phifer, C.B., Berthoud, H.R., Duodenal nutrient infusions differentially affect sham feeding and Fos expression in rat brain stem. Am. J. Physiol. 274 (1998), R1725–R1733.
68. Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N., Duparc, T., Lichtenstein, L., et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23 (2017), 107–113.
69. Prawitt, J., Abdelkarim, M., Stroeve, J.H., Popescu, I., Duez, H., Velagapudi, V.R., Dumont, J., Bouchaert, E., van Dijk, T.H., Lucas, A., et al. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes 60 (2011), 1861–1871.
70. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60.
71. Rani, R.P., Anandharaj, M., Ravindran, A.D., Characterization of bile salt hydrolase from Lactobacillus gasseri FR4 and demonstration of its substrate specificity and inhibitory mechanism using molecular docking analysis. Front. Microbiol., 8, 2017, 1004.
72. Rasmussen, B.A., Breen, D.M., Luo, P., Cheung, G.W., Yang, C.S., Sun, B., Kokorovic, A., Rong, W., Lam, T.K., Duodenal activation of cAMP-dependent protein kinase induces vagal afferent firing and lowers glucose production in rats. Gastroenterology 142 (2012), 834–843.e3.
73. Reimann, F., Habib, A.M., Tolhurst, G., Parker, H.E., Rogers, G.J., Gribble, F.M., Glucose sensing in L cells: a primary cell study. Cell Metab. 8 (2008), 532–539.
74. Richards, P., Pais, R., Habib, A.M., Brighton, C.A., Yeo, G.S., Reimann, F., Gribble, F.M., High fat diet impairs the function of glucagon-like peptide-1 producing L-cells. Peptides 77 (2016), 21–27.
75. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., Griffin, N.W., Lombard, V., Henrissat, B., Bain, J.R., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
76. Riserus, U., Willett, W.C., Hu, F.B., Dietary fats and prevention of type 2 diabetes. Prog. Lipid Res. 48 (2009), 44–51.
77. Rocca, A.S., LaGreca, J., Kalitsky, J., Brubaker, P.L., Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology 142 (2001), 1148–1155.
78. Roglic, G., World Health Organization, Global Report on Diabetes. 2016, World Health Organization.
79. Rossetti, L., Giaccari, A., DeFronzo, R.A., Glucose toxicity. Diabetes Care 13 (1990), 610–630.
80. Sayin, S.I., Wahlstrom, A., Felin, J., Jantti, S., Marschall, H.U., Bamberg, K., Angelin, B., Hyotylainen, T., Oresic, M., Backhed, F., Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17 (2013), 225–235.
81. Scherer, T., Lindtner, C., Zielinski, E., O'Hare, J., Filatova, N., Buettner, C., Short term voluntary overfeeding disrupts brain insulin control of adipose tissue lipolysis. J. Biol. Chem. 287 (2012), 33061–33069.
82. Schiff, E.R., Small, N.C., Dietschy, J.M., Characterization of the kinetics of the passive and active transport mechanisms for bile acid absorption in the small intestine and colon of the rat. J. Clin. Invest. 51 (1972), 1351–1362.
83. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., Huttenhower, C., Metagenomic biomarker discovery and explanation. Genome Biol., 12, 2011, R60.
84. Shah, B.P., Liu, P., Yu, T., Hansen, D.R., Gilbertson, T.A., TRPM5 is critical for linoleic acid-induced CCK secretion from the enteroendocrine cell line, STC-1. Am. J. Physiol. Cell Physiol. 302 (2012), C210–C219.
85. Shin, N.R., Lee, J.C., Lee, H.Y., Kim, M.S., Whon, T.W., Lee, M.S., Bae, J.W., An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63 (2014), 727–735.
86. Soupene, E., Kuypers, F.A., Mammalian long-chain acyl-CoA synthetases. Exp. Biol. Med. (Maywood) 233 (2008), 507–521.
87. Thaler, J.P., Yi, C.X., Schur, E.A., Guyenet, S.J., Hwang, B.H., Dietrich, M.O., Zhao, X., Sarruf, D.A., Izgur, V., Maravilla, K.R., et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122 (2012), 153–162.
88. Trabelsi, M.S., Daoudi, M., Prawitt, J., Ducastel, S., Touche, V., Sayin, S.I., Perino, A., Brighton, C.A., Sebti, Y., Kluza, J., et al. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat. Commun., 6, 2015, 7629.
89. Tremaroli, V., Karlsson, F., Werling, M., Stahlman, M., Kovatcheva-Datchary, P., Olbers, T., Fandriks, L., le Roux, C.W., Nielsen, J., Backhed, F., Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 22 (2015), 228–238.
90. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
91. Turnbaugh, P.J., Ridaura, V.K., Faith, J.J., Rey, F.E., Knight, R., Gordon, J.I., The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med., 1, 2009, 6ra14.
92. Usman, Hosono, A., Hypocholesterolemic effect of Lactobacillus gasseri SBT0270 in rats fed a cholesterol-enriched diet. J. Dairy Res. 68 (2001), 617–624.
93. Vazquez-Baeza, Y., Pirrung, M., Gonzalez, A., Knight, R., EMPeror: a tool for visualizing high-throughput microbial community data. Gigascience, 2, 2013, 16.
94. Vrieze, A., Van Nood, E., Holleman, F., Salojarvi, J., Kootte, R.S., Bartelsman, J.F., Dallinga-Thie, G.M., Ackermans, M.T., Serlie, M.J., Oozeer, R., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143 (2012), 913–916.e7.
95. Wang, P.Y., Caspi, L., Lam, C.K., Chari, M., Li, X., Light, P.E., Gutierrez-Juarez, R., Ang, M., Schwartz, G.J., Lam, T.K., Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 452 (2008), 1012–1016.
96. Wang, Q., Garrity, G.M., Tiedje, J.M., Cole, J.R., Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73 (2007), 5261–5267.
97. Wang, Z., Zeng, X., Mo, Y., Smith, K., Guo, Y., Lin, J., Identification and characterization of a bile salt hydrolase from Lactobacillus salivarius for development of novel alternatives to antibiotic growth promoters. Appl. Environ. Microbiol. 78 (2012), 8795–8802.
98. Whelan, F.J., Verschoor, C.P., Stearns, J.C., Rossi, L., Luinstra, K., Loeb, M., Smieja, M., Johnstone, J., Surette, M.G., Bowdish, D.M., The loss of topography in the microbial communities of the upper respiratory tract in the elderly. Ann. Am. Thorac. Soc. 11 (2014), 513–521.
99. Wirth, R., Bodi, N., Maroti, G., Bagyanszki, M., Talapka, P., Fekete, E., Bagi, Z., Kovacs, K.L., Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes. PLoS One, 9, 2014, e110440.
100. Woltman, T., Castellanos, D., Reidelberger, R., Role of cholecystokinin in the anorexia produced by duodenal delivery of oleic acid in rats. Am. J. Physiol. 269 (1995), R1420–R1433.
101. Woltman, T., Reidelberger, R., Effects of duodenal and distal ileal infusions of glucose and oleic acid on meal patterns in rats. Am. J. Physiol. 269 (1995), R7–R14.
102. Wu, H., Esteve, E., Tremaroli, V., Khan, M.T., Caesar, R., Manneras-Holm, L., Stahlman, M., Olsson, L.M., Serino, M., Planas-Felix, M., et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23 (2017), 850–858.
103. Xu, F., Guo, F., Hu, X.J., Lin, J., Crystal structure of bile salt hydrolase from Lactobacillus salivarius. Acta Crystallogr. F Struct. Biol. Commun. 72 (2016), 376–381.
104. Yadav, H., Jain, S., Sinha, P.R., Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23 (2007), 62–68.
105. Ye, Y., Identification and quantification of abundant species from pyrosequences of 16S rRNA by consensus alignment. Proceedings (IEEE Int. Conf. Bioinformatics Biomed.) 2010 (2011), 153–157.
106. Yue, J.T., Abraham, M.A., Bauer, P.V., LaPierre, M.P., Wang, P., Duca, F.A., Filippi, B.M., Chan, O., Lam, T.K., Inhibition of glycine transporter-1 in the dorsal vagal complex improves metabolic homeostasis in diabetes and obesity. Nat. Commun., 7, 2016, 13501.
107. Zadeh-Tahmasebi, M., Duca, F.A., Rasmussen, B.A., Bauer, P.V., Cote, C.D., Filippi, B.M., Lam, T.K., Activation of short and long chain fatty acid sensing machinery in the ileum lowers glucose production in vivo. J. Biol. Chem. 291 (2016), 8816–8824.
108. Zhou, J., Martin, R.J., Tulley, R.T., Raggio, A.M., McCutcheon, K.L., Shen, L., Danna, S.C., Tripathy, S., Hegsted, M., Keenan, M.J., Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am. J. Physiol. Endocrinol. Metab. 295 (2008), E1160–E1166.